Skip to main content
Top
Published in: Clinical Rheumatology 2/2021

01-02-2021 | Polymyositis | Original Article

The association between myositis-specific autoantibodies and muscle pathologies in idiopathic inflammatory myopathies

Authors: Qiu Xu, Qiu-Xiang Li, Fang-Fang Bi, Hui-Qian Duan, Yue-Bei Luo, Huan Yang

Published in: Clinical Rheumatology | Issue 2/2021

Login to get access

Abstract

Objective

To investigate specific muscle pathologies of different kinds of myositis-specific autoantibodies (MSAs) in idiopathic inflammatory myopathy (IIM) patients.

Methods

One hundred eleven Chinese patients from Xiangya Hospital, Central South University diagnosed with IIMs according to European Neuromuscular Centre (ENMC) criteria were included. Clinical manifestation, myositis-specific autoantibodies, and histologic findings were evaluated to explore the pattern of necrosis, regeneration, and perifascicular atrophy, inflammatory cells in IIM patients with different MSAs.

Results

Anti-SRP group has the lowest muscle strength scores, the highest creatine kinase levels, the most severe degree of necrosis and regeneration (1.90[0.80–3.95], 1.00[0.30–1.71]), and the lowest positive rate of MHC-I staining (35.71%). The anti-MDA5 group demonstrates the mildest pathological changes, with the fewest necrotic and regenerated muscle fibers (0.00[0.00–0.50], 0.00[0.00–0.00]), and the fewest inflammatory cell infiltration, and the highest muscle strength scores. The anti-NXP2 group has the most frequent inflammatory infiltrates, especially CD4+ T cells (31.14[15.00–39.00]). The patients with anti-NXP2 and the anti-TIF1γ antibodies show higher frequency of punched-out fibers (1.50[0.00–3.70], 0.00[0.00–1.00]) and perifascicular atrophy (71.43%, 55.56%). As for anti-synthetase antibodies (ASAs), the anti-Jo-1 group shows the most frequent rate of perifascicular necrosis (60%), while other ASA groups do not show perifascicular necrosis.

Conclusions

Of the MSAs, the anti-SRP antibody leads to the most severe muscle involvement, while the anti-MAD5 antibody the mildest. The anti-NXP2 and anti-TIF1γ groups have the most typical “DM” pathology.
Key Points
• Anti-SRP group shows severe muscle pathology while anti-MDA5 group shows the mildest.
• Anti-NXP2 group has the most frequent inflammatory infiltrates. Pouch-out fibers and perifascicular atrophy are more prevalent in anti-NXP2 and anti-TIF1γ groups.
• Anti-Jo-1 group is often accompanied by perifascicular necrosis, while other anti-synthetase antibody groups are not.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hoogendijk JE, Amato AA, Lecky BR, Choy EH, Lundberg IE, Rose MR, Vencovsky J, de Visser M, Hughes RA (2004) 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands. Neuromuscul Disord 14:337–345. https://doi.org/10.1016/j.nmd.2004.02.006 Hoogendijk JE, Amato AA, Lecky BR, Choy EH, Lundberg IE, Rose MR, Vencovsky J, de Visser M, Hughes RA (2004) 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands. Neuromuscul Disord 14:337–345. https://​doi.​org/​10.​1016/​j.​nmd.​2004.​02.​006
5.
go back to reference Betteridge Z, Tansley S, Shaddick G, Chinoy H, Cooper RG, New RP, Lilleker JB, Vencovsky J, Chazarain L, Danko K, Nagy-Vincze M, Bodoki L, Dastmalchi M, Ekholm L, Lundberg IE, McHugh N, UKMyonet contributors (2019) Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients. J Autoimmun 101:48–55. https://doi.org/10.1016/j.jaut.2019.04.001CrossRefPubMedPubMedCentral Betteridge Z, Tansley S, Shaddick G, Chinoy H, Cooper RG, New RP, Lilleker JB, Vencovsky J, Chazarain L, Danko K, Nagy-Vincze M, Bodoki L, Dastmalchi M, Ekholm L, Lundberg IE, McHugh N, UKMyonet contributors (2019) Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients. J Autoimmun 101:48–55. https://​doi.​org/​10.​1016/​j.​jaut.​2019.​04.​001CrossRefPubMedPubMedCentral
6.
go back to reference Hou Y, Luo YB, Dai T, Shao K, Li W, Zhao Y, Lu JQ, Yan C (2018) Revisiting pathological classification criteria for adult idiopathic inflammatory myopathies: in-depth analysis of muscle biopsies and correlation between pathological diagnosis and clinical manifestations. J Neuropathol Exp Neurol 77:395–404. https://doi.org/10.1093/jnen/nly017 Hou Y, Luo YB, Dai T, Shao K, Li W, Zhao Y, Lu JQ, Yan C (2018) Revisiting pathological classification criteria for adult idiopathic inflammatory myopathies: in-depth analysis of muscle biopsies and correlation between pathological diagnosis and clinical manifestations. J Neuropathol Exp Neurol 77:395–404. https://​doi.​org/​10.​1093/​jnen/​nly017
8.
go back to reference Habers GE, Huber AM, Mamyrova G, Targoff IN, O'Hanlon TP, Adams S et al. (2016) Brief report: association of myositis autoantibodies, clinical features, and environmental exposures at illness onset with disease course in juvenile myositis. Arthritis Rheumatol 68:761–768. https://doi.org/10.1002/art.39466 Habers GE, Huber AM, Mamyrova G, Targoff IN, O'Hanlon TP, Adams S et al. (2016) Brief report: association of myositis autoantibodies, clinical features, and environmental exposures at illness onset with disease course in juvenile myositis. Arthritis Rheumatol 68:761–768. https://​doi.​org/​10.​1002/​art.​39466
11.
21.
go back to reference Chen F, Wang D, Shu X, Nakashima R, Wang G (2012) Anti-MDA5 antibody is associated with A/SIP and decreased T cells in peripheral blood and predicts poor prognosis of ILD in Chinese patients with dermatomyositis. Rheumatol Int 32:3909–3915. https://doi.org/10.1007/s00296-011-2323-y Chen F, Wang D, Shu X, Nakashima R, Wang G (2012) Anti-MDA5 antibody is associated with A/SIP and decreased T cells in peripheral blood and predicts poor prognosis of ILD in Chinese patients with dermatomyositis. Rheumatol Int 32:3909–3915. https://​doi.​org/​10.​1007/​s00296-011-2323-y
23.
go back to reference Sato S, Hoshino K, Satoh T, Fujita T, Kawakami Y, Fujita T, Kuwana M. (2009) RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: association with rapidly progressive interstitial lung disease. Arthritis Rheum 60:2193–2200. https://doi.org/10.1002/art.24621 Sato S, Hoshino K, Satoh T, Fujita T, Kawakami Y, Fujita T, Kuwana M. (2009) RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: association with rapidly progressive interstitial lung disease. Arthritis Rheum 60:2193–2200. https://​doi.​org/​10.​1002/​art.​24621
29.
go back to reference Allenbach Y, Arouche-Delaperche L, Preusse C, Radbruch H, Butler-Browne G, Champtiaux N, Mariampillai K, Rigolet A, Hufnagl P, Zerbe N, Amelin D, Maisonobe T, Louis-Leonard S, Duyckaerts C, Eymard B, Goebel HH, Bergua C, Drouot L, Boyer O, Benveniste O, Stenzel W (2018) Necrosis in anti-SRP(+) and anti-HMGCR(+)myopathies: role of autoantibodies and complement. Neurology 90:e507–e517. https://doi.org/10.1212/WNL.0000000000004923CrossRefPubMed Allenbach Y, Arouche-Delaperche L, Preusse C, Radbruch H, Butler-Browne G, Champtiaux N, Mariampillai K, Rigolet A, Hufnagl P, Zerbe N, Amelin D, Maisonobe T, Louis-Leonard S, Duyckaerts C, Eymard B, Goebel HH, Bergua C, Drouot L, Boyer O, Benveniste O, Stenzel W (2018) Necrosis in anti-SRP(+) and anti-HMGCR(+)myopathies: role of autoantibodies and complement. Neurology 90:e507–e517. https://​doi.​org/​10.​1212/​WNL.​0000000000004923​CrossRefPubMed
30.
go back to reference Arouche-Delaperche L, Allenbach Y, Amelin D, Preusse C, Mouly V, Mauhin W, Tchoupou GD, Drouot L, Boyer O, Stenzel W, Butler-Browne G, Benveniste O (2017) Pathogenic role of anti-signal recognition protein and anti-3-Hydroxy-3-methylglutaryl-CoA reductase antibodies in necrotizing myopathies: myofiber atrophy and impairment of muscle regeneration in necrotizing autoimmune myopathies. Ann Neurol 81:538–548. https://doi.org/10.1002/ana.24902CrossRefPubMed Arouche-Delaperche L, Allenbach Y, Amelin D, Preusse C, Mouly V, Mauhin W, Tchoupou GD, Drouot L, Boyer O, Stenzel W, Butler-Browne G, Benveniste O (2017) Pathogenic role of anti-signal recognition protein and anti-3-Hydroxy-3-methylglutaryl-CoA reductase antibodies in necrotizing myopathies: myofiber atrophy and impairment of muscle regeneration in necrotizing autoimmune myopathies. Ann Neurol 81:538–548. https://​doi.​org/​10.​1002/​ana.​24902CrossRefPubMed
34.
go back to reference Adams RA, Fernandes-Cerqueira C, Notarnicola A, Mertsching E, Xu Z, Lo WS, Ogilvie K, Chiang KP, Ampudia J, Rosengren S, Cubitt A, King DJ, Mendlein JD, Yang XL, Nangle LA, Lundberg IE, Jakobsson PJ, Schimmel P (2019) Serum-circulating His-tRNA synthetase inhibits organ-targeted immune responses. Cell Mol Immunol. https://doi.org/10.1038/s41423-019-0331-0 Adams RA, Fernandes-Cerqueira C, Notarnicola A, Mertsching E, Xu Z, Lo WS, Ogilvie K, Chiang KP, Ampudia J, Rosengren S, Cubitt A, King DJ, Mendlein JD, Yang XL, Nangle LA, Lundberg IE, Jakobsson PJ, Schimmel P (2019) Serum-circulating His-tRNA synthetase inhibits organ-targeted immune responses. Cell Mol Immunol. https://​doi.​org/​10.​1038/​s41423-019-0331-0
40.
go back to reference Huang K, Li QX, Bi FF, Duan HQ, Mastaglia F, Luo YB, Yang H (2018) Comparative immunoprofiling of polymyositis and dermatomyositis muscles. Int J Clin Exp Pathol 11:3984–3993PubMedPubMedCentral Huang K, Li QX, Bi FF, Duan HQ, Mastaglia F, Luo YB, Yang H (2018) Comparative immunoprofiling of polymyositis and dermatomyositis muscles. Int J Clin Exp Pathol 11:3984–3993PubMedPubMedCentral
41.
go back to reference Xiao Y, Zhu H, Li L, Gao S, Liu D, Dai B, Li Q, Duan H, Yang H, Li Q, Zhang H, Luo H, Zuo X (2019) Global analysis of protein expression in muscle tissues of dermatomyositis/polymyosisits patients demonstrated an association between dysferlin and human leucocyte antigen a. Rheumatology (Oxford) 58:1474–1484. https://doi.org/10.1093/rheumatology/kez085CrossRef Xiao Y, Zhu H, Li L, Gao S, Liu D, Dai B, Li Q, Duan H, Yang H, Li Q, Zhang H, Luo H, Zuo X (2019) Global analysis of protein expression in muscle tissues of dermatomyositis/polymyosisits patients demonstrated an association between dysferlin and human leucocyte antigen a. Rheumatology (Oxford) 58:1474–1484. https://​doi.​org/​10.​1093/​rheumatology/​kez085CrossRef
42.
go back to reference Englund P, Nennesmo I, Klareskog L, Lundberg IE (2002) Interleukin-1alpha expression in capillaries and major histocompatibility complex class I expression in type II muscle fibers from polymyositis and dermatomyositis patients: important pathogenic features independent of inflammatory cell clusters in muscle tissue. Arthritis Rheum 46:1044–1055. https://doi.org/10.1002/art.10140CrossRefPubMed Englund P, Nennesmo I, Klareskog L, Lundberg IE (2002) Interleukin-1alpha expression in capillaries and major histocompatibility complex class I expression in type II muscle fibers from polymyositis and dermatomyositis patients: important pathogenic features independent of inflammatory cell clusters in muscle tissue. Arthritis Rheum 46:1044–1055. https://​doi.​org/​10.​1002/​art.​10140CrossRefPubMed
43.
go back to reference Pandya JM, Venalis P, Al-Khalili L, Shahadat Hossain M, Stache V, Lundberg IE et al. (2016) CD4+ and CD8+ CD28(null) T cells are cytotoxic to autologous muscle cells in patients with polymyositis. Arthritis Rheumatol 68:2016–2026. https://doi.org/10.1002/art.39650 Pandya JM, Venalis P, Al-Khalili L, Shahadat Hossain M, Stache V, Lundberg IE et al. (2016) CD4+ and CD8+ CD28(null) T cells are cytotoxic to autologous muscle cells in patients with polymyositis. Arthritis Rheumatol 68:2016–2026. https://​doi.​org/​10.​1002/​art.​39650
Metadata
Title
The association between myositis-specific autoantibodies and muscle pathologies in idiopathic inflammatory myopathies
Authors
Qiu Xu
Qiu-Xiang Li
Fang-Fang Bi
Hui-Qian Duan
Yue-Bei Luo
Huan Yang
Publication date
01-02-2021
Publisher
Springer International Publishing
Published in
Clinical Rheumatology / Issue 2/2021
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-020-05274-2

Other articles of this Issue 2/2021

Clinical Rheumatology 2/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.